Insentials
ActiveSummary
Insentials has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.9m and a net result of €279,180. Equity is growing by about 76% per year across the filed financial years. Its solvency ranks better than 86% of 997 sector peers (NACE 10, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Overview
- Staff
- 13.9 FTE
- Equity
- €2.9m
- Profit
- €279,180
- Holdings
- 1
- Eutopia Gestion SASDirector · permanent representative Antoine Fine
- FG InvestmentDirector · permanent representative Evrard de Montgolfier
Why 68raises risk2 changes of registered office in 24 monthsFounded in 2021lowers riskSize: 13.9 FTE, total assets €4.0mLiquidity: current ratio 3.42, cash €1.6mShow the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 10, small): better than 90% on solvency, 97% on liquidity, 37% on profitability and 62% on growth.
The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 5 accounts on average 13 days after the deadline; the sector median (NACE 10) for financial year 2024 is 4 days before the deadline, and 38% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · abbreviated…
- Annual accounts filedfinancial year 2024 · abbreviated…
- Registered officeDirector in office · Registered-office…
Financials · financial year 2025, abbreviated format
2021 to 2025, 5 financial years
The operating result falls in 2025; 2025 is 74% below 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Average staff in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 10, Manufacture of food products: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
- 2024 Net result +59%, Staff (FTE) +167% on 2023. The accounts now follow the abbreviated format, last year the micro format.
Peer companies
Historical observationOf the 6,782 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 96.7% are still going.
- Small
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
For this company itself Checked computes a higher bankruptcy probability: 1.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,782 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €0.05m | €0.3m | €0.5m | €0.8m | ▲ 56.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.01m | €0.02m | €0.01m | €0.05m | €0.1m | ▲ 127% |
| Other operating charges640/8 | - | €0.005m | €0.001m | €0.09m | €0.01m | ▼ 89.5% |
| Non-recurring operating charges66A | - | - | €0.04m | €0 | - | - |
| Gross operating margin9900 | €0.02m | €0.2m | €1.6m | €2.8m | €1.5m | ▼ 45.6% |
| Operating profit (loss)9901 | €0.006m | €0.1m | €1.3m | €2.1m | €0.6m | ▼ 73.8% |
| Financial income75/76B | €30 | €0 | €0.003m | €0.003m | €179 | ▼ 94.8% |
| Recurring financial income75 | €30 | €0 | €0.003m | €0.003m | €179 | ▼ 94.8% |
| Financial charges65/66B | €0.004m | €0.005m | €0.03m | €0.1m | €0.2m | ▲ 44.6% |
| Recurring financial charges65 | €0.004m | €0.005m | €0.03m | €0.1m | €0.2m | ▲ 44.6% |
| Profit (loss) for the period before taxes9903 | €0.002m | €0.1m | €1.3m | €2.0m | €0.4m | ▼ 80.4% |
| Income taxes67/77 | - | €0.02m | €0.3m | €0.5m | €0.1m | ▼ 76.7% |
| Profit (loss) for the period9904 | €0.002m | €0.1m | €0.9m | €1.5m | €0.3m | ▼ 81.5% |
| Transfer to tax-exempt reserves689 | - | - | - | €0.6m | €0.2m | ▼ 62.4% |
| Profit (loss) for the period to be appropriated9905 | €0.002m | €0.1m | €0.9m | €1.0m | €0.07m | ▼ 92.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €0.3m | €0.4m | €2.2m | €3.8m | €4.0m | ▲ 4.6% |
| Fixed assets21/28 | €0.1m | €0.1m | €0.2m | €0.5m | €0.6m | ▲ 20.5% |
| Intangible fixed assets21 | €0.1m | €0.09m | €0.1m | €0.3m | €0.3m | ▼ 7.3% |
| Tangible fixed assets22/27 | - | €0.02m | €0.04m | €0.2m | €0.3m | ▲ 58.0% |
| Plant, machinery and equipment23 | - | €0.003m | €0.001m | €269 | €0.008m | ▲ 2,931% |
| Furniture and vehicles24 | - | €0.007m | €0.02m | €0.1m | €0.1m | ▼ 0.1% |
| Other tangible fixed assets26 | - | €0.008m | €0.02m | €0.1m | €0.2m | ▲ 126% |
| Financial fixed assets28 | - | €0.008m | €0.008m | €0.008m | €0.009m | ▲ 13.3% |
| Current assets29/58 | €0.2m | €0.3m | €2.0m | €3.3m | €3.4m | ▲ 2.0% |
| Stocks and contracts in progress3 | €0.01m | €0.03m | €0.2m | €1.4m | €1.0m | ▼ 26.0% |
| Stocks30/36 | €0.01m | €0.03m | €0.2m | €1.4m | €1.0m | ▼ 26.0% |
| Amounts receivable within one year40/41 | €0.08m | €0.1m | €1.1m | €0.5m | €0.7m | ▲ 47.3% |
| Trade receivables40 | €0.02m | €0.07m | €0.5m | €0.3m | €0.4m | ▲ 66.2% |
| Other amounts receivable41 | €0.06m | €0.04m | €0.6m | €0.2m | €0.2m | ▲ 22.4% |
| Cash at bank and in hand54/58 | €0.08m | €0.2m | €0.7m | €1.5m | €1.6m | ▲ 5.2% |
| Deferred charges and accrued income490/1 | €0.005m | €0 | €0.009m | €0.009m | €0.1m | ▲ 1,361% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €0.3m | €0.4m | €2.2m | €3.8m | €4.0m | ▲ 4.6% |
| Equity10/15 | €0.1m | €0.2m | €1.1m | €2.7m | €2.9m | ▲ 10.5% |
| Contributions10/11 | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | = |
| Reserves13 | - | - | - | €0.6m | €0.8m | ▲ 37.6% |
| Tax-exempt reserves132 | - | - | - | €0.6m | €0.8m | ▲ 37.6% |
| Profit (loss) carried forward14 | €0.002m | €0.07m | €1.0m | €2.0m | €2.0m | ▲ 3.5% |
| Amounts payable17/49 | €0.2m | €0.3m | €1.0m | €1.2m | €1.1m | ▼ 8.8% |
| Amounts payable after more than one year17 | €0.1m | €0.1m | €0 | €0.03m | €0.06m | ▲ 59.5% |
| Financial debts170/4 | €0.1m | €0.1m | €0 | €0.03m | €0.06m | ▲ 59.5% |
| Amounts payable within one year42/48 | €0.05m | €0.1m | €1.0m | €1.1m | €1.0m | ▼ 13.9% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.008m | €0.02m | ▲ 107% |
| Trade debts44 | €0.05m | €0.08m | €0.6m | €0.9m | €0.8m | ▼ 12.7% |
| Suppliers440/4 | €0.05m | €0.08m | €0.6m | €0.9m | €0.8m | ▼ 12.7% |
| Taxes, remuneration and social security45 | - | €0.02m | €0.3m | €0.07m | €0.1m | ▲ 44.4% |
| Taxes450/3 | - | €0.02m | €0.3m | €0.01m | €0.02m | ▲ 35.2% |
| Remuneration and social security454/9 | - | - | €0.03m | €0.06m | €0.09m | ▲ 46.4% |
| Other amounts payable47/48 | - | €0.05m | €0.05m | €0.1m | €0.05m | ▼ 62.4% |
| Accrued charges and deferred income492/3 | - | - | - | - | €0.04m | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.002m | €0.1m | €0.9m | €1.5m | €0.3m | ▼ 81.5% |
| + Depreciation and write-downs630 | €0.01m | €0.02m | €0.01m | €0.05m | €0.1m | ▲ 127% |
| Operating cash flow (approximation) | €0.01m | €0.1m | €1.0m | €1.6m | €0.4m | ▼ 74.4% |
| Investment in fixed assets (approximation) | - | -€0.03m | -€0.06m | -€0.4m | -€0.2m | ▲ 45.8% |
| Change in cash | - | €0.1m | €0.5m | €0.8m | €0.08m | ▼ 90.5% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (5)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 24-07-2026 | 2026-00327986 |
| 31-12-2024 | abbreviated format | 23-07-2025 | 2025-00303700 |
| 31-12-2023 | micro format | 20-08-2024 | 2024-00357678 |
| 31-12-2022 | micro format | 31-08-2023 | 2023-00387274 |
| 31-12-2021 | micro format | 31-08-2022 | 2022-20410194 |
Similar companies · same sector, comparable size
Subsidies and aid
Flemish government
2023 to 2025 · 5 entries · €49,997 awarded · €49,997 paid| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2025 | 1 | €12,572 | €12,572 |
| 2024 | 2 | €17,930 | €17,930 |
| 2023 | 2 | €19,495 | €19,495 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Board 2
Day-to-day management 1
Permanent representatives 3
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Day-to-day management
| Name | Functions and periods |
|---|---|
| Eutopia Gestion SAS |
|
| FG Investment |
|
| PHARMAFOOD |
|
Owners and capital
Capital and shareholders
- 29-11-2024 Capital stated in the deed · 100 shares
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
100%
According to the 2025 annual accounts of Insentials and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
2 current directorsThe board mandates are listed below; here you explore them as a network.
History
Insentials was incorporated on 12 March 2021 as a private limited company.1 The registered office moved to Drongen in 2023, to Sint-Martens-Latem in 2024 and to Deinze in 2025.234 Total assets rose from €277,245 in 2021 to €4.0m in 2025 and headcount from 3 full-time equivalents in 2023 to 13.9 in 2025.5
Acts, filings and financial milestones
24-01
Gazette deed
Registered officeDirector in office · Registered-office move4 facts ▸
- Other provision, “deposit reference”, 25012876 (deed in Dutch)
- Board meeting, 04-10-2024
- Director in office, Amandine De Paepe (sole director)
- Registered-office move, Gentsesteenweg 194/0001-9800 Deinze
29-11
Gazette deed
Appointments: FG Investment, Eutopia Gestion SAS and PharmafoodPermanent representatives: Evrard de Montgolfier, Antoine Fine and Amandine De Paepe · Capital · Power of attorney16 facts ▸
- Capital
- Other provision, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Director appointment, FG Investment (director (not named in the articles))
- Director appointment, Eutopia Gestion SAS (director (not named in the articles))
- Director appointment, Pharmafood (managing director)
- Permanent representative, Evrard de Montgolfier
- Permanent representative, Antoine Fine
- Permanent representative, Amandine De Paepe
- Other provision, “info@insentials.com, website-e-mail” (deed in Dutch)
- Power of attorney
- General meeting, 14-11-2024
- Kind of shares, “wijziging rechten tot afzonderlijke te creëren soort, zelfde rechten en voordelen,behoudens Aandeelhoudersovereenkomst” (deed in Dutch)
- +4 further facts in this act
25-11
Gazette deed
Appointments: FG Investment BV (director) and Eutopia Gestion SAS (director)Permanent representatives: Evrard de Montgolfier, Antoine Fine and Amandine De Paepe · Power of attorney · Registered-office move12 facts ▸
- General meeting, 09-10-2024
- Director appointment, FG Investment BV (director)
- Director appointment, Eutopia Gestion SAS (director)
- Permanent representative, Evrard de Montgolfier
- Permanent representative, Antoine Fine
- Board composition, Pharmafood BV (director)
- Board composition, FG Investment BV (director)
- Board composition, Eutopia Gestion SAS (director)
- Board meeting, 09-10-2024
- Power of attorney, Pharmafood BV
- Permanent representative, Amandine De Paepe (vaste vertegenwoordiger belast met uitvoering van mandaat van gedelegeerd bestuurder)
- Registered-office move, Xavier de Cocklaan 13,9831 Sint-Martens-Latem
14-12
Gazette deed
Registered officeRegistered-office move2 facts ▸
- Board meeting, 01-11-2023
- Registered-office move, Keuzekouter 20-9031 Drongen
About the unread acts
Of the 7 Belgian Official Gazette deeds we know for this company, 4 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 22 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Food safety, FASFC
1 siteEnvironmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 44054A0501/00T002 | Flanders | 1,376 m² | 1 · 852 m² | 12.5 m · 1 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “1/ De verkoop,fabricage en studie van voedingssupplementen,kruiden,sportproducten,thee,poeders,medical devices en andere voedingsmiddelen…” (deed in Dutch)
17 activities (deed in Dutch)
- 1/ De verkoop,fabricage en studie van voedingssupplementen,kruiden,sportproducten,thee,poeders,medical devices en andere voedingsmiddelen.
- 2/ De invoer,de uitvoer,doorvoer,opslag,de verkoop en het geven van franchise van bovenvermelde producten,evenals van grondstoffen en de moederlogen bestemd voor de bereiding van deze producten,alsook van planten,gewassen en etherische oliën,zonder dat deze opsomming beperkend is.
- 3/ Het schrijven van voedingsboeken.
- 4/ Het maken van alle farmaceutische,farmacologische en toxicologische studies en onderzoeken betreffende alle commerciële en industriële activiteiten,de organisatie van vennootschappen en ondernemingen,het verrichten van marktonderzoek en promotie.
- 5/ Het verlenen van advies en bijstand en het ontwikkelen van activiteiten in de farmaceutische sector en in de gezondheidssector en meer specifiek de voedingssupplementen.
- 6/ Praktijk als voedingsdeskundige.
- 7/ Het adviseren,ontwikkelen en uitvoeren van marketing acties voor derden.
- 8/ Het voeren van promotionele acties,van welke aard dan ook,voor derden.
- 9/ Het ontwerpen van publicitaire teksten,slogans en artikelen.
- 10/ Het verlenen van advies met betrekking tot informatie-en promotiecampagnes.
- 11/ Het outsourcen van medewerkers met als doel het geven van advies aan derden,het begeleiden van projecten of het uitvoeren van promotionele acties.- Het voeren van mediacampagnes voor derden.
- 12/ Het ter beschikking stellen van management;het voeren van bedrijfsmanagement in de meest ruime zin van het woord,daarin begrepen het uitoefenen van de functie van bestuurder,of vereffenaar van binnenlandse en buitenlandse vennootschappen;van het uitoefenen van bedrijfsleiding en het organiseren ervan;het optreden als mandataris voor alle binnenlandse en buitenlandse vennootschappen;alsook het waarnemen van beheer op alle niveaus,zowel voor eigen rekening als voor rekening of in deelneming met derden.
- 13/ Het oprichten van gebouwen of laten oprichten van gebouwen,het verwerven,beheren,exploiteren,huren en verhuren,vervreemden van onroerende zaken en/of zakelijke rechten op onroerende goederen,hetzij voor eigen rekening hetzij voor rekening van derden in de ruimste zin van het woord.
- Alle onroerend en roerend goed verrichtingen uitvoeren,die rechtstreeks of onrechtstreeks verband houden met haar voorwerp of activiteiten die zullen bijdragen tot haar ontwikkeling.
- De vennootschap zal de leiding en de controle,in haar hoedanigheid van bestuurder,vereffenaar of anderszins,kunnen uitoefenen over,en advies verschaffen aan aanverwante ondernemingen en dochtervennootschappen.
- De vennootschap mag bij wijze van inbreng in speciën of in natura,fusie,onderschrijving,deelneming,financiële tussenkomst of anderszins,belangen nemen in andere bestaande of op te richten vennootschappen of ondernemingen,in België of in het buitenland,waarvan het voorwerp verwant of analoog is met het hare of van aard haar voorwerp te bevorderen.
- De vennootschap kan zowel tot waarborg van eigen verbintenissen als tot waarborg van verbintenissen van derden borg stellen,onder meer door haar goederen in hypotheek of in pand te geven,inclusief de eigen handelszaak.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- INSENTIALS
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, adres over te brengen naar tweetalig gebied Brussel Hoofdstad of Nederlands taalgebied door eenvoudige beslissing…” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Gekozen uit B-bestuurders, collegiaal bestuursorgaan (Raad van Bestuur)” (deed in Dutch)“Al dan niet ten kosteloze titel, algemene vergadering bepaalt bezoldiging beslissend met meerderheid van stemmen en rekening houdend met…” (deed in Dutch)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Op naam, register van aandelen op naam met wettelijk voorgeschreven vermeldingen” (deed in Dutch)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Aandelen, overdrachtsbeperkingen en procedures zoals opgenomen in Aandeelhouders-overeenkomst” (deed in Dutch)
- Share issue ruleHow and by whom new shares can be issued.
- “Overeenkomstig toepasselijke wetgeving en bepalingen in Aandeelhoudersovereenkomst, bestaande aandeelhouders” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Friday of June
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vormen vereist voor statutenwijziging, ontbinding door beslissing algemene vergadering” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- One provision in the deed